Twist Bioscience (TWST) Net Income (2017 - 2026)

Twist Bioscience (TWST) has reported Net Income for 10 consecutive years, with -$44.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Income fell 11.93% year-over-year to -$44.0 million; the TTM figure through Mar 2026 stood at -$81.2 million (up 57.5% YoY), while the FY2025 annual figure was -$77.7 million, up 62.79% from the prior year.
• Net Income eased to -$44.0 million in Q1 2026 per TWST's latest filing, from -$30.5 million in the prior quarter.
• Across five years, Net Income topped out at $20.4 million in Q2 2025 and bottomed at -$85.6 million in Q2 2024.
• Historically, Net Income has averaged -$43.4 million across 5 years, with a median of -$44.0 million in 2026.
• Annual changes were most pronounced in 2022 — Net Income plunged 59.99% — and 2025, when it soared 123.82%.
• Twist Bioscience's Net Income stood at -$41.8 million in 2022, then declined by 2.78% to -$43.0 million in 2023, then climbed by 26.5% to -$31.6 million in 2024, then climbed by 3.45% to -$30.5 million in 2025, then slumped by 44.3% to -$44.0 million in 2026.
• Business Quant data shows TWST's Net Income at -$44.0 million in Q1 2026, -$30.5 million in Q4 2025, and -$27.1 million in Q3 2025.